Regeneron Pharmaceuticals 2016 Bank of America Healthcare Conference

Regeneron Pharmaceuticals presented at the Bank of America Merrill Lynch Global Healthcare Conference on September 14, 2016, with CFO Robert Landry discussing the company's leading biopharmaceutical pipeline and innovative technology platforms including VelociSuite, bispecifics, genomics, and CRISPR. The presentation outlined Regeneron's commitment to delivering new medicines across late-stage programs and diverse R&D initiatives.